It is aimed at girls who are in the fifth and sixth grades of elementary school, as well as first grade of junior high school and girls 11, 12 and 13 years of age who are not in school.
In addition, girls 14 and 15 years of age who have not received any dose of HPV vaccine previously will be vaccinated.
Vaccinations will be given at the Institute’s Family Medicine Units, as well as in the state’s public schools.
The Mexican Social Security Institute (IMSS) in Yucatan will participate in the sectoral vaccination campaign against Human Papilloma Virus (HPV), which will be carried out from September 15 to December 15, 2023, in all Family Medicine Units of the Social Security in the state, from 8:00 am to 8:00 pm.
Dr. Flor Rodriguez Melo, head of the Medical Services Department, said that the aim of this campaign is to contribute to reducing the incidence of HPV infection, a virus associated with the presence of cervical cancer.
In this regard, Dr. Rodriguez Melo extends a warm invitation to parents and guardians of girls between 11 and 15 years of age to be vaccinated with the HPV vaccine, which protects against the main types of the virus, with types 16 and 18 being responsible for approximately 70% of all cervical neoplasms.
HPV infection is considered the most common sexually transmitted infection (STI), affecting more than half of sexually active women and men.
This campaign is aimed at girls in the fifth and sixth grades of primary school and first year of secondary school and girls 11, 12 and 13 years of age who are not in school, as well as girls 14 and 15 years of age who have not previously received a dose of HPV vaccine.
The vaccination also targets cisgender and transgender women, aged 11-49 years, living with HIV. Pre-vaccination HPV testing is not required.
Dr. Rodriguez Melo emphasizes that they should not be vaccinated if they have a history of severe allergy to any of the components of the vaccine; when there is fever equal to or greater than 38.5 °C. It should be noted that the HPV vaccine is not contraindicated in women with reduced defenses (immunosuppression) due to illness or medication.
TYT Newsroom
